null Ahsan Alam, MDCM, M.Sc.
Chronic kidney disease • acute kidney injury • autosomal dominant polycystic kidney disease • kidney transplantation • clinical epidemiology
My research focuses on better understanding factors that influence kidney disease onset and progression, and their related complications. I am particularly interested in the care of patients with autosomal dominant polycystic kidney disease and how treatments can modify disease progression. Finally, I am interested in the care of living donor candidates and expanding opportunities for safe living kidney donation.
Sandal S, Dendukuri N, Wang S, Guadagno E, Ekmekjian T, Alam A. Efficacy of educational interventions in improving measures of living donor kidney transplantation activity: a systematic review and meta-analysis. Transplantation. 2019 Apr 1. [Epub ahead of print] PMID: 30946222.
Cornec-Le Gall E, Alam A, Perrone RD. Autosomal dominant polycystic kidney disease. Lancet. 2019 Mar 2;393(10174):919-935. PMID: 30819518.
Soroka S, Alam A, Bevilacqua M, Girard LP, Komenda P, Loertscher R, McFarlane P, Pandeya S, Tam P, Bichet DG. Updated Canadian Expert Consensus on Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease. Can J Kidney Health Dis. 2018 Oct 12;5:2054358118801589. PMID: 30345064.
Mavrakanas TA, Sniderman AD, Barré PE, Vasilevsky M, Alam A. High Ultrafiltration Rates Increase Troponin Levels in Stable Hemodialysis Patients. Am J Nephrol. 2016;43(3):173-8. PMID: 27064739.
Chau EM, Manns BJ, Garg AX, Sood MM, Kim SJ, Naimark D, Nesrallah GE, Soroka SD, Beaulieu M, Dixon S, Alam A, Tangri N; Canadian Kidney Knowledge Translation and Generation Network (CANN-NET). Knowledge Translation Interventions to Improve the Timing of Dialysis Initiation: Protocol for a Cluster Randomized Trial. Can J Kidney Health Dis. 2016 Sep 14;3:2054358116665257. PMID: 28270916.